Yasuo Sakamoto
- Geriatrics and Gerontology top 1%
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 21
- Pancreatic and Hepatic Oncology Research 16
- Surgery top 1%
- Esophageal Cancer Research and Treatment 36
- Esophageal and GI Pathology 21
-
- Gastric Cancer Management and Outcomes 32
- Cancer Research top 5%
-
- Epigenetics and DNA Methylation 23
-
- Hepatocellular Carcinoma Treatment and Prognosis 19
-
- Gastrointestinal Tumor Research and Treatment 13
- Co-authors
- Naoya YoshidaMasayuki WatanabeYuji MiyamotoYoshifumi BabaHideo BabaMasaaki IwatsukiRyuma TokunagaTakatsugu Ishimoto
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Yasuo Sakamoto
167 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Geriatrics and Gerontology 344
- Oncology 1.8k
- Surgery 2.0k
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 618
Countries citing papers authored by Yasuo Sakamoto
This map shows the geographic impact of Yasuo Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Sakamoto more than expected).
Fields of papers citing papers by Yasuo Sakamoto
This network shows the impact of papers produced by Yasuo Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Sakamoto. The network helps show where Yasuo Sakamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasuo Sakamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosisbreakdown → | 2016 | 365 |
| 2 | 2016 | 1 | |
| 3 | 2015 | 29 | |
| 4 | 2015 | 280 | |
| 5 | 2014 | 8 | |
| 6 | 2014 | 55 | |
| 7 | 2014 | 17 | |
| 8 | 2013 | 52 | |
| 9 | 2013 | 14 | |
| 10 | 2013 | 10 | |
| 11 | 2012 | 4 | |
| 12 | 2010 | 2 | |
| 13 | 2009 | 0 | |
| 14 | 2007 | 0 | |
| 15 | 2005 | 1 | |
| 16 | 2002 | 3 | |
| 17 | 2001 | 43 | |
| 18 | 1998 | 3 | |
| 19 | 1997 | 27 | |
| 20 | 1994 | 90 |
About Yasuo Sakamoto
Yasuo Sakamoto is a scholar working on Hepatology, Oncology and Gastroenterology, having authored 179 papers that have together received 5.0k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (36 papers), Gastric Cancer Management and Outcomes (32 papers), Epigenetics and DNA Methylation (23 papers), Colorectal Cancer Treatments and Studies (21 papers), Esophageal and GI Pathology (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Gastrointestinal Tumor Research and Treatment (13 papers). The work is most often cited by research in Geriatrics and Gerontology (344 citations), Oncology (1.8k citations) and Surgery (2.0k citations). Yasuo Sakamoto has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Naoya Yoshida, Masayuki Watanabe, Yuji Miyamoto, Yoshifumi Baba, Hideo Baba, Masaaki Iwatsuki, Ryuma Tokunaga, Takatsugu Ishimoto, Junji Kurashige and Shiro Iwagami. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.